Diamyd Medical

Last updated

Diamyd Medical AB (Stockholm NASDAQ, First North) is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.

Diamyd Medical logo Diamyd Medical Logo.svg
Diamyd Medical logo

The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. [1]


References

  1. ↑ "Annual Report 2021/2022" (PDF). Diamyd Medical AB. Retrieved 20 February 2023.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.